Your Doctor Had 7 Minutes. Let's Understand Your Labs.

Your doctor called with your results.

"Everything looks normal," they said. Or maybe: "Your A1C is a little high — watch what you eat." Or the one that leaves you staring at the ceiling at 3am: "We'll want to keep an eye on this."

Then they were gone. Seven minutes. Appointment over.

And you're left holding a printout full of abbreviations and reference ranges, wondering what any of it actually means for you.

The 7-Minute Problem

Doctors in the U.S. average fewer than 7 minutes with each patient during a standard visit. That's not a criticism — it's a system problem. There are too many patients, too many charts, too much documentation. Primary care physicians carry panels of 1,500–2,500 patients. There is no version of this where your doctor has 45 minutes to walk you through your comprehensive metabolic panel.

The result: you leave with results but not understanding.

That gap has consequences. When patients don't understand their labs, they don't know what questions to ask at the next appointment. They don't know whether a "borderline" number is something to act on or just noise. They don't know if the trend over the last three visits is getting better or worse.

They just wait for the next call.

What Your Labs Are Actually Telling You

Let's take a common example: you got flagged for prediabetes. Your A1C came back at 5.8%.

Your doctor said to watch your diet. Maybe they handed you a pamphlet. And that was it.

Here's what they didn't have time to tell you:

What 5.8% actually means: Your A1C reflects your average blood sugar over the past 2–3 months. Normal is below 5.7%. Diabetic is 6.5% and above. At 5.8%, you're in the prediabetic range — but you're closer to the low end than the high end. That context matters.

What to watch alongside it: A1C doesn't tell the whole story. Fasting glucose, insulin levels, and triglycerides together paint a much clearer picture of what's happening with your metabolic health. If your fasting insulin is elevated alongside that A1C, that's a different conversation than if it's normal.

What the trend means: A single A1C result is a snapshot. If this is your first flagged result, that's very different from a number that's been climbing over the last two years of labs. Trends matter more than any single data point.

What questions to bring to your doctor: "Is my fasting insulin normal?" "Should we track this quarterly?" "Are there specific foods that are most likely driving this?" These are the questions that turn a 7-minute appointment into an actually useful one.

This is the kind of context that should come with your results. It almost never does.

The Information Gap Isn't a Failure — It's Just an Unsolved Problem

Most of the time, "your labs are normal" is accurate. Your doctor is telling you the truth. The numbers are within the reference ranges printed on the page.

But reference ranges are population-level benchmarks. They tell you where you fall relative to a large, not-particularly-healthy population. They don't tell you what's optimal for you, at your age, with your history, alongside your other numbers.

"Normal" for a 55-year-old woman navigating perimenopause is a different conversation than "normal" for a 35-year-old man. TSH levels, estradiol, ferritin — these markers shift significantly through life transitions, and the standard ranges often don't reflect that.

Your doctor knows this. They just don't have time to explain it.

What Phi Does

Phi Longevity is a lab analysis tool built for exactly this moment — the one after the phone call, when you're sitting with your results and don't know what they mean.

Building it required solving a problem I'd spent my career on in a different context: how do you take complex data and make it immediately useful to the person who needs it? I worked for years at Oracle and AWS helping organizations do exactly that — not making technology for technology's sake, but making technology work for the people on the other end of it. Phi is that same problem applied to the most personal data any of us has.

You upload your labs. We analyze them in plain English.

Here's what that looks like:

We flag what's worth paying attention to — not just what's outside the reference range, but what's trending in a direction you should know about.

We give you context — your A1C in isolation is one data point; your A1C alongside your fasting glucose, insulin, and triglycerides is a metabolic picture.

We explain what each marker does — in language that doesn't require a medical degree.

We help you prepare for your next appointment — with specific questions based on your actual results.

We're not replacing your doctor. We're making the 7 minutes you have with them count.

Built With Clinicians, Not Just Engineers

The analysis behind Phi isn't just AI running on raw data. Our clinical team includes MDs, naturopathic doctors, and a strength and conditioning specialist — each bringing a different lens to the same question: what does this actually mean for the patient? A cardiovascular specialist reads an ApoB result differently than an integrative physician reads it alongside triglycerides, insulin, and lifestyle markers. A strength and conditioning coach sees what a metabolic panel means for recovery and performance in ways a lab report never surfaces.

That's not an accident — it mirrors something I saw repeatedly in technology: cross-functional teams consistently deliver better outcomes for clients than siloed specialists working alone. The same is true in health. When complementary expertise converges on your data, the picture gets sharper. That's the standard we built Phi against.

What This Looks Like in Practice

A user uploaded her labs after getting a "borderline thyroid" flag on her TSH. Her doctor had told her they'd "watch it."

She didn't understand what watching it meant, or what she was watching for.

After uploading her panel, she could see: her TSH was elevated at 4.8 mIU/L (above the 4.0 conventional cutoff), but her free T4 and free T3 were both within range. That pattern — high TSH with normal free hormones — is called subclinical hypothyroidism. It's common, it's often asymptomatic, and in many cases the recommendation genuinely is to monitor rather than treat immediately.

She also learned what to ask at her follow-up: "Should we test thyroid antibodies (TPO)? That would tell us if this is autoimmune in origin, which changes how we watch it."

That question changed the conversation. Her doctor ordered the antibody test. It came back positive for Hashimoto's — a common autoimmune thyroid condition that often precedes more significant TSH elevation. Now they had a real plan.

One question. From understanding one result.

Your Labs Have More to Say

If you've gotten lab results recently that you didn't fully understand — a prediabetes flag, a cholesterol number that concerned you, a thyroid result that felt ambiguous — this is what Phi is for.

Upload your most recent labs. We'll show you what's flagged, explain what it means, and help you walk into your next appointment with the right questions.

Your doctor had 7 minutes. You deserve more than that.

Get your free analysis →